Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Jump To

Vibativ

Generic name: telavancin
Drug class: Glycopeptide antibiotics

Medically reviewed by  A Ras MD.

What is Vibativ?

Vibativ is a prescription antibacterial medicine used alone, or with other medicines, to treat adults with certain types of germs (bacteria) that cause serious skin infections, Hospital-Acquired Bacterial Pneumonia (HABP), Ventilator-Associated Bacterial Pneumonia (VABP).

It is not known if Vibativ is safe or effective in children.

Description

VIBATIV contains telavancin hydrochloride a lipoglycopeptide antibacterial that is a synthetic derivative of vancomycin. The chemical name of telavancin hydrochloride is vancomycin, N3”-[2(decylamino-)ethyl]-29[[(phosphonomethyl)-amino]-methyl]-hydrochloride. Telavancin hydrochloride has the following chemical structure:

Figure 1: Telavancin Hydrochloride

Figure 1

Telavancin hydrochloride is an off-white to slightly colored amorphous powder with the empirical formula C80H106Cl2N11O27P•xHCl (where x = 1 to 3) and a free-base molecular weight of 1755.6. It is highly lipophilic and slightly soluble in water.

VIBATIV is a sterile, preservative-free, white to slightly colored lyophilized powder containing telavancin hydrochloride (equivalent to 750 mg of telavancin as the free base) for intravenous use. The inactive ingredients are Hydroxypropylbetadex, (hydroxypropyl-beta-cyclodextrin) (7500 mg per 750 mg telavancin), mannitol (937.5 mg per 750 mg telavancin), and sodium hydroxide and hydrochloric acid used in minimal quantities for pH adjustment. When reconstituted, it forms a clear to slightly colored solution with a pH of 4.5 (4.0 to 5.0).

What is the most important information I should know about Vibativ?

Vibativ can cause serious side effects, including:

  • Increased risk of death. Vibativ was associated with an increased risk of death compared to vancomycin in people who already had kidney problems and were treated for bacterial pneumonia that you can get when you are in the hospital.
  • New or worsening kidney problems. Your healthcare provider should do a blood test to check your kidneys before you start, while you receive, and after you stop receiving Vibativ.
  • Vibativ may harm your unborn baby. If you are a woman who can become pregnant, your healthcare provider should do a pregnancy test before you start receiving Vibativ.
    • Talk to your healthcare provider if you are pregnant or plan to become pregnant. Your healthcare provider will decide if Vibativ is the right medicine for you.
    • Women who can become pregnant should use effective birth control (contraception) while receiving Vibativ and for 2 days after the last dose of Vibativ. Talk to your healthcare provider if you have questions about birth control.
    • If you become pregnant while receiving Vibativ, tell your healthcare provider right away. Talk to your healthcare provider about taking part in the Vibativ Pregnancy Registry. This is a study to learn how Vibativ affects pregnancy and babies. You can enroll in this registry by calling 1-877-484-2700.

Who should not use Vibativ?

Do not receive Vibativ if you:

  • are allergic to telavancin or any of the ingredients in Vibativ. See the end of this Medication Guide for a complete list of ingredients in Vibativ.

What should I tell my healthcare provider before using Vibativ?

Before you receive Vibativ, tell your healthcare provider about all of your medical conditions, including if you:

  • have had a serious allergic reaction to Vibativ or vancomycin.
  • have kidney problems.
  • have diabetes.
  • have, have had or have a family history of heart problems, including QTc prolongation.
  • have high blood pressure. are pregnant or plan to become pregnant. See “What is the most important information I should know about Vibativ?”
  • are breastfeeding or plan to breastfeed. It is not known if Vibativ passes into breast milk. You and your healthcare provider should decide if you will breastfeed while receiving Vibativ.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Vibativ and other medicines can affect each other causing side effects.
Especially tell your healthcare provider if you take:

  • a Non-Steroidal Anti-Inflammatory Drug (NSAID)
  • certain blood pressure medicines called Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin Receptor Blockers (ARBs)
  • water pills (diuretics)
  • a blood thinner
  • medicine to control your heart rate or rhythm (antiarrhythmics)

Ask your healthcare provider or pharmacist for a list of these medicines, if you are not sure.
Know the medicines you take. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

How should I use Vibativ?

  • Vibativ is given by your healthcare provider through a needle placed into your vein (IV infusion) slowly over 1 hour, 1 time each day, for 7 to 21 days.
  • Do not stop receiving Vibativ unless your healthcare provider tells you to, even if you feel better.
  • Your healthcare provider will do blood tests before you start and while you receive Vibativ.

What are the possible side effects of Vibativ?

Vibativ may cause serious side effects, including:
See “What is the most important information I should know about Vibativ?”

  • Serious allergic reactions. Allergic reactions can happen in people who receive Vibativ, even after only 1 dose. Stop receiving Vibativ and get emergency medical help right away if you get any of the following symptoms of a severe allergic reaction:
    • hives
    • trouble breathing or swallowing
    • swelling of the lips, tongue, face
    • throat tightness, hoarseness
    • rapid heartbeat
    • faint
  • Infusion-related reactions. People who receive Vibativ too quickly can have a certain type of skin reaction called “Red-man Syndrome”. Signs and symptoms of Red-man Syndrome can include:
    • red color (flushing)
    • rash
    • itching
  • Problems with the electrical system of your heart (QTc prolongation). Tell your healthcare provider right away if you have a change in your heartbeat such as a fast or irregular heartbeat or if you had a fainting episode.

Call your healthcare provider right away if you have any of the serious side effects listed above.
The most common side effects of Vibativ include:

  • change in your sense of taste
  • nausea
  • vomiting
  • foamy urine
  • diarrhea

Tell your healthcare provider about any side effect that bothers you or that does not go away. These are not all the possible side effects of Vibativ. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of Vibativ

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide.
This Medication Guide summarizes the most important information about Vibativ. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about Vibativ that is written for health professionals.

What are the ingredients in Vibativ?

Active ingredient: telavancin hydrochloride

Inactive ingredients: hydroxypropylbetadex, Ph. Eur (hydroxypropyl-beta- cyclodextrin), mannitol, sodium hydroxide and hydrochloric acid

What is Vibativ?

Vibativ is a prescription antibacterial medicine used alone, or with other medicines, to treat adults with certain types of germs (bacteria) that cause:

  • serious skin infections
  • Hospital-Acquired Bacterial Pneumonia (HABP)
  • Ventilator-Associated Bacterial Pneumonia (VABP)

It is not known if Vibativ is safe or effective in children.

What is the most important information I should know about Vibativ?

Vibativ can cause serious side effects, including:

  • Increased risk of death. Vibativ was associated with an increased risk of death compared to vancomycin in people who already had kidney problems and were treated for bacterial pneumonia that you can get when you are in the hospital.
  • New or worsening kidney problems. Your healthcare provider should do a blood test to check your kidneys before you start, while you receive, and after you stop receiving Vibativ.
  • Vibativ may harm your unborn baby. If you are a woman who can become pregnant, your healthcare provider should do a pregnancy test before you start receiving Vibativ.
    • Talk to your healthcare provider if you are pregnant or plan to become pregnant. Your healthcare provider will decide if Vibativ is the right medicine for you.
    • Women who can become pregnant should use effective birth control (contraception) while receiving Vibativ and for 2 days after the last dose of Vibativ. Talk to your healthcare provider if you have questions about birth control.
    • If you become pregnant while receiving Vibativ, tell your healthcare provider right away. Talk to your healthcare provider about taking part in the Vibativ Pregnancy Registry. This is a study to learn how Vibativ affects pregnancy and babies. You can enroll in this registry by calling 1-877-484-2700.

Who should not use Vibativ?

Do not receive Vibativ if you:

  • are allergic to telavancin or any of the ingredients in Vibativ. See the end of this Medication Guide for a complete list of ingredients in Vibativ.

What should I tell my healthcare provider before using Vibativ?

Before you receive Vibativ, tell your healthcare provider about all of your medical conditions, including if you:

  • have had a serious allergic reaction to Vibativ or vancomycin.
  • have kidney problems.
  • have diabetes.
  • have, have had or have a family history of heart problems, including QTc prolongation.
  • have high blood pressure. are pregnant or plan to become pregnant. See “What is the most important information I should know about Vibativ?”
  • are breastfeeding or plan to breastfeed. It is not known if Vibativ passes into breast milk. You and your healthcare provider should decide if you will breastfeed while receiving Vibativ.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Vibativ and other medicines can affect each other causing side effects.
Especially tell your healthcare provider if you take:

  • a Non-Steroidal Anti-Inflammatory Drug (NSAID)
  • certain blood pressure medicines called Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin Receptor Blockers (ARBs)
  • water pills (diuretics)
  • a blood thinner
  • medicine to control your heart rate or rhythm (antiarrhythmics)

Ask your healthcare provider or pharmacist for a list of these medicines, if you are not sure.
Know the medicines you take. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

How should I use Vibativ?

  • Vibativ is given by your healthcare provider through a needle placed into your vein (IV infusion) slowly over 1 hour, 1 time each day, for 7 to 21 days.
  • Do not stop receiving Vibativ unless your healthcare provider tells you to, even if you feel better.
  • Your healthcare provider will do blood tests before you start and while you receive Vibativ.

What are the possible side effects of Vibativ?

Vibativ may cause serious side effects, including:
See “What is the most important information I should know about Vibativ?”

  • Serious allergic reactions. Allergic reactions can happen in people who receive Vibativ, even after only 1 dose. Stop receiving Vibativ and get emergency medical help right away if you get any of the following symptoms of a severe allergic reaction:
    • hives
    • trouble breathing or swallowing
    • swelling of the lips, tongue, face
    • throat tightness, hoarseness
    • rapid heartbeat
    • faint
  • Infusion-related reactions. People who receive Vibativ too quickly can have a certain type of skin reaction called “Red-man Syndrome”. Signs and symptoms of Red-man Syndrome can include:
    • red color (flushing)
    • rash
    • itching
  • Problems with the electrical system of your heart (QTc prolongation). Tell your healthcare provider right away if you have a change in your heartbeat such as a fast or irregular heartbeat or if you had a fainting episode.

Call your healthcare provider right away if you have any of the serious side effects listed above.
The most common side effects of Vibativ include:

  • change in your sense of taste
  • nausea
  • vomiting
  • foamy urine
  • diarrhea

Tell your healthcare provider about any side effect that bothers you or that does not go away. These are not all the possible side effects of Vibativ. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of Vibativ

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide.
This Medication Guide summarizes the most important information about Vibativ. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about Vibativ that is written for health professionals.

What are the ingredients in Vibativ?

Active ingredient: telavancin hydrochloride

Inactive ingredients: hydroxypropylbetadex, Ph. Eur (hydroxypropyl-beta- cyclodextrin), mannitol, sodium hydroxide and hydrochloric acid

Label

Principal Display Panel – 750 mg/vial Vial Label

  • NDC 66220-315-11
  • VIBATIV®
  • (telavancin) for injection
  • 750 mg/vial
  • For Intravenous Infusion Only
  • Single Dose Vial-
  • Discard Unused Portion
  • ATTENTION: Dispense with enclosed
    Medication Guide.
  • Rx Only
  • CUMBERLAND®
    PHARMACEUTICALS
Vibativ

SRC: NLM .

Read Next Article